Risk factors associated with relapse after methotrexate dose reduction in patients with rheumatoid arthritis receiving golimumab and methotrexate combination therapy.
Kitamura N, Kobayashi H, Nagasawa Y, Sugiyama K, Tsuzuki H, Tanikawa Y, Ikumi N, Okada Y, Takahashi Y, Asai S, Tamura N, Ogasawara M, Kawamoto T, Kuwatsuru R, Tamaki H, Kidoguchi G, Tateishi M, Kimura M, Mochida Y, Harigane K, Shimazaki T, Koike T, Tanimura K, Kataoka H, Amano K, Yasuoka H, Takei M.
Kitamura N, et al. Among authors: tsuzuki h.
Int J Rheum Dis. 2023 Jun;26(6):1058-1066. doi: 10.1111/1756-185X.14695. Epub 2023 Apr 14.
Int J Rheum Dis. 2023.
PMID: 37058849